Published in Br J Pharmacol on January 01, 1977
Glucagon and vasopressin interactions on Ca2+ movements in isolated hepatocytes. Biochem J (1986) 1.10
Calcium: its modulation in liver by cross-talk between the actions of glucagon and calcium-mobilizing agonists. Biochem J (1993) 1.10
Interactions between receptors that increase cytosolic calcium and cyclic AMP in guinea-pig liver cells. Br J Pharmacol (1984) 1.08
Multiple mechanisms by which protein kinase A potentiates inositol 1,4,5-trisphosphate-induced Ca2+ mobilization in permeabilized hepatocytes. Biochem J (1993) 1.04
Isoprenaline- and noradrenaline-induced hyperpolarization of guinea-pig liver cells. Br J Pharmacol (1981) 0.86
The role of cyclic nucleotides and related compounds in nerve-mediated vasodilatation in the cat submandibular gland. Br J Pharmacol (1980) 0.85
The effects of adrenoceptor agonists and antagonists on plasma potassium concentration in anaesthetized guinea-pigs, rabbits and rats. Br J Pharmacol (1985) 0.84
Purinergic signalling in the liver in health and disease. Purinergic Signal (2013) 0.83
Vasopressin-stimulated Ca2+ influx in rat hepatocytes is inhibited in high-K+ medium. Biochem J (1989) 0.83
Further observations on the interaction between glutamate and aspartate on lobster muscle. Br J Pharmacol (1979) 0.76
Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells. J Physiol (1975) 5.14
The action of adrenaline on serum potassium. J Physiol (1936) 3.82
The interaction of cyclic nucleotides and calcium in the control of cellular activity. Adv Cyclic Nucleotide Res (1975) 3.38
Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine. J Pharm Pharmacol (1965) 3.11
Effects of noradrenaline on potassium reflux, membrane potential and electrolyte levels in tissue slices prepared from guinea-pig liver. J Physiol (1972) 2.81
Suppression of spontaneous spike generation by catecholamines in the smooth muscle of the guinea-pig taenia coli. Proc R Soc Lond B Biol Sci (1969) 1.80
A comparison of the effects of adenosine triphosphate with noradrenaline and with the inhibitory potential of the guinea-pig taenia coli. J Physiol (1973) 1.68
The receptors concerned in the actions of catecholamines on glucose release, membrane potential and ion movements in guinea-pig liver. J Physiol (1972) 1.56
Action of adrenaline on the serum potassium. J Physiol (1937) 1.52
The role of alpha- and beta- adrenergic receptors in some actions of catecholamines on intestinal smooth muscle. J Physiol (1967) 1.46
A QUANTITATIVE INVESTIGATION OF THE RELATIONSHIP BETWEEN RATE OF ACCESS OF A DRUG TO RECEPTOR AND THE RATE OF ONSET OR OFFSET OF ACTION. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1964) 1.37
Epinephrine-induced hypokalemia: relation to liver and skeletal muscle. J Pharmacol Exp Ther (1972) 1.30
Effects of sympathomimetic amines on 45Ca efflux from liver slices. Br J Pharmacol (1976) 1.25
Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch Int Pharmacodyn Ther (1965) 1.24
Kalemotropic effect of epinephrine: analysis with adrenergic agonists and antagonists. Am J Physiol (1971) 1.15
Separate phosphodiesterases for the hydrolysis of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in rat liver. J Biol Chem (1973) 1.13
A quantitative study of alpha adrenergic receptors in the spleen and aorta of the rabbit. J Pharmacol Exp Ther (1972) 1.11
Regulation of cyclic nucleotide phosphodiesterase. Adv Cyclic Nucleotide Res (1975) 1.11
Beta-adrenergic effects on rat myometrium: mechanisms of membrane hyperpolarization. Am J Physiol (1973) 1.09
Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines. J Pharmacol Exp Ther (1975) 1.06
Effect of adrenergic amines on the membrane potential of guinea-pig liver parenchymal cells in short term tissue culture. Experientia (1972) 1.05
MECHANISM OF THE POTASSIUM MOBILIZING ACTION OF EPINEPHRINE AND GLUCAGON. J Pharmacol Exp Ther (1963) 0.94
Cyclic adenosine and guaosine monophosphates and gucagon: effect on liver membrane potentials. Science (1971) 0.94
Proceedings: Comparison of the effects of selective alpha and beta-receptor agonists on intracellular cyclic AMP levels and glycogen phosphorylase activity in guinea-pig liver. Br J Pharmacol (1975) 0.92
The role of cyclic AMP in the control of hepatic glucose production by glucagon and insulin. Adv Cyclic Nucleotide Res (1972) 0.91
Adrenergic beta blockade and changes in plasma potassium following epinephrine administration. Eur J Pharmacol (1971) 0.88
Antibronchoconstrictor activity of two new phosphodiesterase inhibitors, a triazolopyrazine (ICI 58 301) and a triazolopyrimidine (ICI 63 197). J Pharm Pharmacol (1973) 0.88
Effects of isoprenaline and phenylephrine on plasma potassium: role of the liver. Arch Int Pharmacodyn Ther (1975) 0.86
Effects of beta-adrenergic catecholamines on potassium transport in turkey erythrocytes. J Biol Chem (1975) 0.86
A comparison between the influence of pindolol and propranolol on the response of plasma potassium to catecholamines. Arzneimittelforschung (1976) 0.83
Calcium and cAMP as interrelated intracellular messengers. Ann N Y Acad Sci (1975) 0.83
Hepatic clearance of adenosine 3:5-cyclic monophosphate from plasma in the rat. Biochem J (1975) 0.78
Proceedings: An interaction between the alpha and beta actions of catecholamines in guinea-pig liver slices. Br J Pharmacol (1976) 0.77
Apamin blocks certain neurotransmitter-induced increases in potassium permeability. Nature (1979) 3.93
Effects of quinine and apamin on the calcium-dependent potassium permeability of mammalian hepatocytes and red cells. J Physiol (1981) 3.01
Effects of noradrenaline on potassium reflux, membrane potential and electrolyte levels in tissue slices prepared from guinea-pig liver. J Physiol (1972) 2.81
Toxins in the characterization of potassium channels. Trends Neurosci (1989) 2.10
Are accelerometers a useful tool for measuring disease activity in children with eczema? Validity, responsiveness to change, and acceptability of use in a clinical trial setting. Br J Dermatol (2012) 1.97
Influence of chloride ions on changes in membrane potential during prolonged application of carbachol to frog skeletal muscle. Br J Pharmacol (1973) 1.77
The effect of noradrenaline on the permeability of depolarized intestinal smooth muscle to inorganic ions. J Physiol (1967) 1.67
Classification and properties of peripheral adrenergic receptors. Br Med Bull (1973) 1.60
The receptors concerned in the actions of catecholamines on glucose release, membrane potential and ion movements in guinea-pig liver. J Physiol (1972) 1.56
The effect of noradrenaline on the end-plate potential in twitch fibres of the frog. J Physiol (1968) 1.47
The role of alpha- and beta- adrenergic receptors in some actions of catecholamines on intestinal smooth muscle. J Physiol (1967) 1.46
Adrenergic blocking drugs as tools in the study of the actions of catecholamines on the smooth muscle membrane. Ann N Y Acad Sci (1967) 1.40
Nucleation and growth of mineral crystals in bone studied by small-angle X-ray scattering. Calcif Tissue Int (1991) 1.35
Effects of catecholamines, ATP and ionophore A23187 on potassium and calcium movements in isolated hepatocytes. Nature (1979) 1.32
A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technol Assess (2011) 1.25
Mineral crystals in calcified tissues: a comparative study by SAXS. J Bone Miner Res (1992) 1.22
Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channel. J Med Chem (1998) 1.17
The effect of noradrenaline on the ion permeability of isolated mammalian hepatocytes, studied by intracellular recording. J Physiol (1987) 1.09
Interactions between receptors that increase cytosolic calcium and cyclic AMP in guinea-pig liver cells. Br J Pharmacol (1984) 1.08
Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channel. J Med Chem (2000) 1.07
Extracellular lipid peroxidation of selective white-rot fungus, Ceriporiopsis subvermispora. FEMS Microbiol Lett (1999) 1.05
Blockade by WB 4101 of alpha-adrenoceptors in the rat vas deferens and guinea-pig taenia caeci. Eur J Pharmacol (1978) 1.05
Antagonism of an indirectly acting agonist: block by propranolol and sotalol of the action of tyramine on rat heart. Eur J Pharmacol (1980) 1.04
N-acetylaspartylglutamate: an endogenous peptide with high affinity for a brain "glutamate" receptor. Proc Natl Acad Sci U S A (1983) 1.03
Dequalinium: a potent inhibitor of apamin-sensitive K+ channels in hepatocytes and of nicotinic responses in skeletal muscle. Eur J Pharmacol (1993) 1.02
Discrimination between subtypes of apamin-sensitive Ca(2+)-activated K+ channels by gallamine and a novel bis-quaternary quinolinium cyclophane, UCL 1530. Br J Pharmacol (1996) 1.01
SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neurones. J Physiol (2001) 1.01
Effects of isomers of the alpha-agonist amidephrine on arterial and tracheal muscle in vitro. Eur J Pharmacol (1970) 0.97
N-Acetylaspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tract. Proc Natl Acad Sci U S A (1985) 0.97
Mechanically loaded ex vivo bone culture system 'Zetos': systems and culture preparation. Eur Cell Mater (2006) 0.96
Calcium-activated potassium channels in liver cells. Cell Calcium (1983) 0.95
Analysis of the interaction between histamine H2-receptor antagonists and pentagastrin [proceedings]. Agents Actions (1978) 0.95
Effects of noradrenaline on the membrane potential and ionic permeability of parenchymal cells in the liver of the guinea-pig. Nature (1969) 0.95
Proceedings: Comparison of the effects of selective alpha and beta-receptor agonists on intracellular cyclic AMP levels and glycogen phosphorylase activity in guinea-pig liver. Br J Pharmacol (1975) 0.92
Neuromuscular blocking agents inhibit receptor-mediated increases in the potassium permeability of intestinal smooth muscle. Br J Pharmacol (1985) 0.92
The mechanism of the blockade by trifluoperazine of some actions of phenylephrine on liver and smooth muscle. Biochem Pharmacol (1981) 0.90
Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma. Br J Cancer (2013) 0.87
Compounds that block both intermediate-conductance (IK(Ca)) and small-conductance (SK(Ca)) calcium-activated potassium channels. Br J Pharmacol (2000) 0.87
Copper-dependent depolymerization of lignin in the presence of fungal metabolite, pyridine. J Biotechnol (1998) 0.86
bis-Quinolinium cyclophanes: 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane (UCL 1848), a highly potent and selective, nonpeptidic blocker of the apamin-sensitive Ca(2+)-activated K(+) channel. J Med Chem (2000) 0.85
Indomethacin inhibits thrombin-, but not thyroxin-stimulated resorption of fetal rat limb bones. Prostaglandins (1986) 0.84
Properties of a cell volume-sensitive potassium conductance in isolated guinea-pig and rat hepatocytes. J Physiol (1992) 0.84
The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil. J Pharm Pharmacol (1996) 0.83
Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells. Br J Pharmacol (1999) 0.81
Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J Bone Miner Res (1989) 0.81
The regulatory role of thyroid hormones in bone cell growth and differentiation. J Nutr (1995) 0.81
Proceedings: Effects of sympathomimetic amines and ouabain on potassium influx in guinea-pig liver slices. J Physiol (1976) 0.80
Comparison of the inhibitory effect of nonsteroidal antiinflammatory drugs on bone prostaglandin synthesis and resorption. J Rheumatol (1988) 0.80
Receptors on the agenda: a symposium to honour Sir James Black. Trends Pharmacol Sci (1994) 0.79
Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes. J Med Chem (2001) 0.78
Synthesis and structure-activity relationships of dequalinium analogues as K+ channel blockers. Investigations on the role of the charged heterocycle. J Med Chem (1995) 0.78
Comparison between the effects of forskolin and calcitonin on bone resorption and osteoclast morphology in vitro. Bone (1989) 0.77
Proceedings: An interaction between the alpha and beta actions of catecholamines in guinea-pig liver slices. Br J Pharmacol (1976) 0.77
Gamma interferon inhibits basal and interleukin 1-induced prostaglandin production and bone resorption in neonatal mouse calvaria. Biochem Biophys Res Commun (1987) 0.77
Cyclosporine A inhibits bone resorption in cultured neonatal mouse calvaria. J Pharmacol Exp Ther (1987) 0.77
On the concept of a bivalent pharmacophore for SKCa channel blockers: synthesis, pharmacological testing, and radioligand binding studies on mono-, bis-, and tris-quinolinium compounds. Arch Pharm (Weinheim) (1996) 0.76
Creatine kinase-MB activity: clinical and laboratory studies of specific immunochemical technique with optimized enzymatic assay. Ann Clin Lab Sci (1983) 0.76
Finding affinity constants for agonists by the irreversible antagonists method. Trends Pharmacol Sci (1989) 0.75
Receptors mediating the effect of catecholamines on glucose release from guinea-pig liver in vitro. Br J Pharmacol (1968) 0.75
Recombinant gamma-interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria. FEBS Lett (1985) 0.75
Suicide attempts 1973-1977--urban Hobart. A further five year follow up reporting a decline. Aust N Z J Psychiatry (1978) 0.75
[Hyperparathyreoidism and chronic lymphocytic leukemia (author's transl)]. Acta Med Austriaca (1981) 0.75
[Severe myopathy and peripheral nerve disease in Cushing's syndrome due to adrenal cortex adenoma]. Wien Med Wochenschr (1974) 0.75
[Migration inhibition of mononuclear cells in idiopathic adrenal insufficiency. Inhibition of migration of mononuclear cells with adrenal microsomes and blocking of the reaction by adrenal antibodies (author's transl)]. Klin Wochenschr (1976) 0.75
Assessment of nicotine uptake from cigarette smoke: comparison of a colorimetric test strip (NicCheck I™) and gas chromatography/mass selective detector. Biomarkers (2001) 0.75
[Treatment of the climacteric syndrome]. Wien Med Wochenschr (1975) 0.75
[Chronic pain management under daily clinical conditions]. Schmerz (2002) 0.75
[New aspects on diagnosis and therapy of primary hyperparathyroidism (author's transl)]. Wien Klin Wochenschr (1980) 0.75
Apamin binding proteins and oligosaccharyltransferases. Toxicon (1996) 0.75
Prostaglandin-related bone resorption in cultured neonatal mouse calvaria: evaluation of biopotency of nonsteroidal anti-inflammatory drugs. Prostaglandins (1985) 0.75
Experimental considerations on the measurement of prostaglandins during long-time incubations of neonatal mouse calvaria. Biochem Biophys Res Commun (1990) 0.75
HL-A antigens in idiopathic Addison's disease. Z Immunitatsforsch Exp Klin Immunol (1975) 0.75
Effect of auranofin on resorption, prostaglandin synthesis and ultrastructure of bone cells in cultured mouse calvaria. J Rheumatol (1989) 0.75
Interferon gamma and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria. J Bone Miner Res (1989) 0.75
[Quality of life of people with schizophrenia in the supported group homes: assessing the individual]. Pflege (2001) 0.75